Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy,International Journal of Nanomedicine

当前位置： X-MOL 学术 › Int. J. Nanomed. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
International Journal of Nanomedicine ( IF 6.6 ) Pub Date : 2021-02-25 , DOI: 10.2147/ijn.s293427
Ruixin Jia , Lesheng Teng , Lingyu Gao , Ting Su , Lu Fu , Zhidong Qiu , Ye Bi

Abstract: Nanomedicines afford unique advantages in therapeutic intervention against tumors. However, conventional nanomedicines have failed to achieve the desired effect against cancers because of the presence of complicated physiological fluids and the tumor microenvironment. Stimuli-responsive drug-delivery systems have emerged as potential tools for advanced treatment of cancers. Versatile nano-carriers co-triggered by multiple stimuli in different levels of organisms (eg, extracorporeal, tumor tissue, cell, subcellular organelles) have aroused widespread interest because they can overcome sequential physiological and pathological barriers to deliver diverse therapeutic “payloads” to the desired targets. Furthermore, multiple stimuli-responsive drug-delivery systems (MSR-DDSs) offer a good platform for co-delivery of agents and reversing multidrug resistance. This review affords a comprehensive overview on the “landscape” of MSR-DDSs against tumors, highlights the design strategies of MSR-DDSs in recent years, discusses the putative advantage of oncotherapy or the obstacles that so far have hindered the clinical translation of MSR-DDSs.

Keywords: multi-stimuli responsive nanoparticles, drug delivery, tumor microenvironment, oncotherapy

更新日期：2021-04-20

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11